二足动物 发表于 2025-3-21 18:12:24

书目名称Clinical Use of Calcium Channel Antagonist Drugs影响因子(影响力)<br>        http://impactfactor.cn/2024/if/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs影响因子(影响力)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs网络公开度<br>        http://impactfactor.cn/2024/at/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs网络公开度学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs被引频次<br>        http://impactfactor.cn/2024/tc/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs被引频次学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs年度引用<br>        http://impactfactor.cn/2024/ii/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs年度引用学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs读者反馈<br>        http://impactfactor.cn/2024/5y/?ISSN=BK0228284<br><br>        <br><br>书目名称Clinical Use of Calcium Channel Antagonist Drugs读者反馈学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=BK0228284<br><br>        <br><br>

Ferritin 发表于 2025-3-21 23:27:39

http://reply.papertrans.cn/23/2283/228284/228284_2.png

繁忙 发表于 2025-3-22 03:31:20

https://doi.org/10.1007/978-1-4842-4810-2s of existing agents include slow-release formulations of nifedipine, verapamil, and diltiazem. From all these agents will be selected those that are longer-acting and provide higher vascular selectivity.

candle 发表于 2025-3-22 08:35:06

http://reply.papertrans.cn/23/2283/228284/228284_4.png

曲解 发表于 2025-3-22 10:03:24

http://reply.papertrans.cn/23/2283/228284/228284_5.png

飓风 发表于 2025-3-22 13:18:37

Clinical Pharmacokinetics of First and Second-Generation Agents,lcium antagonists. There are also other potential drug interactions of a kinetic or dynamic nature that may arise. In general, renal disease has little effect on the pharmacokinetics of calcium antagonists.

飓风 发表于 2025-3-22 17:46:43

http://reply.papertrans.cn/23/2283/228284/228284_7.png

痛苦一下 发表于 2025-3-22 21:36:17

http://reply.papertrans.cn/23/2283/228284/228284_8.png

troponins 发表于 2025-3-23 01:48:54

http://reply.papertrans.cn/23/2283/228284/228284_9.png

颂扬国家 发表于 2025-3-23 05:53:17

Use and Comparative Efficacy in Hypertension and Supraventricular Arrhythmias. Minor Indications,eft ventricular hypertrophy or renal insufficiency. However, the goal blood pressure may not be reached during monotherapy so that drug combinations may be required. Further indications for these compounds are as follows. Verapamil and diltiazem are frequently used in supraventricular tachycardias i
页: [1] 2 3 4 5
查看完整版本: Titlebook: Clinical Use of Calcium Channel Antagonist Drugs; Lionel H. Opie,William A. Coetzee Book 1989 Kluwer Academic Publishers, Boston 1989 angi